PD-1 Expression Affects Cytokine Production by ILC2 and is Influenced by Peroxisome Proliferator-activated Receptor-γ
Overview
Infectious Diseases
Authors
Affiliations
Introduction: Innate lymphoid cells (ILCs) can provide early cytokine help against a variety of pathogens in the lungs and gastrointestinal tract. Type 2 ILC (ILC2) are comparable to T helper 2 cells found in the adaptive immune system, which secrete cytokines such as interleukin 5 (IL-5) and IL-13 and have been found to play roles in host defense against helminth infections and in allergic responses. Recent studies have identified that programmed cell death protein 1 (PD-1) and peroxisome proliferator activated receptor-γ (PPAR-γ) are highly expressed by ILC2. We examined whether PD-1 plays a role in ILC2 function and whether there was any connection between PD-1 and PPAR-γ METHODS: To ensure that only innate immune cells were present, ILC2 cells were examined from RAG1 and PD-1 xRAG1 mice under steady-state or following inoculation with IL-33. We also tested ILC2 generated from bone marrow of RAG1 and PD-1 xRAG1 mice for their production of cytokines. These in vitro-derived ILC2 were also exposed to agonist and antagonist of PPAR-γ.
Results: We found that ILC2 from PD-1 xRAG1 mice had reduced frequencies of IL-5 and IL-13 producing cells both in vitro upon IL-33 stimulation and in vivo following intraperitoneal administration of IL-33 when compared with ILC2 from RAG1 mice. However, by adding IL-2, IL-25, and thymic stromal lymphopoietin to the in vitro cultures, the frequency of IL-5 and IL-13 expressing ILC2 from PD-1 xRAG1 mice became similar to the frequency observed for ILC2 from RAG1 mice. In addition, PPAR-γ agonists and antagonists were found to increase and decrease PD-1 expression on ILC2 respectively.
Conclusions: These findings illustrate that chronic loss of PD-1 plays a role in ILC2 function and PD-1 expression can be modulated by PPAR-γ.
Reuthner K, Aubele P, Menhart K, Rath P, Harrer D, Herr W Front Pharmacol. 2024; 15:1334233.
PMID: 38444946 PMC: 10912635. DOI: 10.3389/fphar.2024.1334233.
Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lung.
Xu S, Zhang Y, Liu X, Liu H, Zou X, Zhang L BMC Biol. 2023; 21(1):218.
PMID: 37833706 PMC: 10576290. DOI: 10.1186/s12915-023-01690-3.
Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in Cancer Immunotherapy.
Burgermeister E Int J Mol Sci. 2023; 24(17).
PMID: 37686465 PMC: 10488039. DOI: 10.3390/ijms241713661.
Tsuji A, Yoshikawa S, Morikawa S, Ikeda Y, Taniguchi K, Sawamura H Explor Target Antitumor Ther. 2023; 4(3):460-473.
PMID: 37455830 PMC: 10344894. DOI: 10.37349/etat.2023.00145.
Chiang C, Chang Y, Wang S, Chen Y, See X, Peng C Cancer Med. 2023; 12(8):9583-9588.
PMID: 36825549 PMC: 10166924. DOI: 10.1002/cam4.5734.